Patents by Inventor Charlotte A. Maltin

Charlotte A. Maltin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic applications of clenbuterol
    Patent number: 5552442
    Abstract: The present invention relates to therapeutic uses of clenbuterol in humans and animals. The uses include retarding or reversing muscular atrophy of denervated muscle, alleviating or reversing loss of function arising from surgical or accidental muscular trauma, and alleviating or reversing the loss of muscle function arising from a humorally mediated catabolic state or from temporary disuse of the muscle. Clenbuterol can be mixed with a beta-adrenergic antagonist to obviate or mitigate unwanted side effects without excessively inhibiting the desired therapeutic effects.
    Type: Grant
    Filed: April 24, 1995
    Date of Patent: September 3, 1996
    Assignee: The Rowett Research Institute
    Inventor: Charlotte A. Maltin
  • Therapeutic applications of beta-adrenergic agonists
    Patent number: 5541188
    Abstract: The present invention relates to therapeutic uses of beta-adrenergic antagonists other than clenbuterol in humans and animals. The uses include retarding or reversing muscle disease such as muscular dystrophy, alleviating or reversing peripheral nervous system disease, alleviating or reversing central nervous system disease, retarding or reversing muscular atrophy of denervated muscle, alleviating or reversing loss of function arising from surgical or accidental muscular trauma, and alleviating or reversing the loss of muscle function arising from a humorally mediated catabolic state or from temporary disuse of the muscle.
    Type: Grant
    Filed: April 24, 1995
    Date of Patent: July 30, 1996
    Assignee: The Rowett Research Institute
    Inventor: Charlotte A. Maltin
  • Therapeutic applications of clenbuterol
    Patent number: 5530029
    Abstract: The present invention relates to therapeutic uses of clenbuterol in humans and animals. The uses include retarding or reversing muscle disease such as muscular dystrophy, alleviating or reversing peripheral nervous system disease, and alleviating or reversing central nervous system disease.
    Type: Grant
    Filed: April 24, 1995
    Date of Patent: June 25, 1996
    Assignee: The Rowett Research Institute
    Inventor: Charlotte A. Maltin